Atorvastatin Calcium
Product Images NDC 53002-2335

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-2335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

A line graph comparing cumulative incidence (%) over 3.5 years between Atorvastatin and Placebo groups. The y-axis shows cumulative incidence from 0.0 to 4.0%, and the x-axis represents time in years from 0.0 to 3.5. Solid line indicates Atorvastatin, dashed line is Placebo. Atorvastatin shows lower cumulative incidence throughout the period. Hazard ratio and p-value are noted in the graph.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

A Kaplan-Meier curve chart showing the cumulative hazard percentage over time in years (up to 5 years) comparing Atorvastatin and placebo groups. The curve for Atorvastatin shows a lower cumulative hazard compared to placebo. The chart includes a hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and a p-value of 0.001, indicating statistical analysis of the data.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

A line graph depicting the percentage of subjects experiencing a major cardiovascular event over time (years) for Atorvastatin 10 mg and 80 mg doses. The horizontal axis shows time to first major cardiovascular endpoint up to 5 years, while the vertical axis shows the percentage of subjects. The graph includes hazard ratio (HR=0.78 with 95% CI 0.69-0.89) and p-value (p=0.0002) statistics for comparison of the two doses.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical structure diagram of atorvastatin calcium trihydrate, showing molecular structure with calcium (Ca2+) and water molecules (3H2O) indicated.*

FDA Label Image

Label Image (Lbl530022335)

Atorvastatin Calcium 20mg tablets packaging label from RPK Pharmaceuticals, Inc. The label specifies 100 tablets per container and includes the product name with dosage strength. It shows the lot number, expiration date, and barcode as part of the packaging details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.